ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

34128 results sorted by trial registration date.
  • Reducing delays in aneurysmal subarachnoid haemorrhage

    Aneurysmal subarachnoid haemorrhage (aSAH) is a rare but devastating form of stroke caused by a ruptured brain aneurysm that kills at least 30% of sufferers within 1 month. Up to 50% of people with aSAH will experience delays greater than 24 hours between onset of aSAH and receiving treatment. This study aims to quantify the time delays in treatment of aSAH for patients across Tasmania and South-East Victoria.

  • Detection of taxane-induced neuropathy using patient-reported outcomes

    Many women receive chemotherapy to decrease the chance of breast cancer recurrence after surgery. These drugs include chemotherapy which is collectively termed taxane-based chemotherapy. Though this is effective in decreasing recurrence, it may cause adverse effects which include peripheral neuropathy, or damage to the nerves, particularly in the hands and feet. This nerve damage can be disabling, causing difficulty in work-related tasking such as typing on a keyboard, difficulty holding objects or fastening buttons. If severe, it can impair the ability to drive or cause falls. We hope to test a better way of detecting peripheral neuropathy than our current grading system, so that early symptoms can be identified and treatment changed to prevent this. Who is it for? You may be eligible for this study if you have a diagnosis of breast cancer and your oncologist plans to use weekly paclitaxel in your treatment plan. Study details If you participate, you will complete a form with details of pre-existing health problems and symptoms of neuropathy You will complete the neuropathy symptom tool (EORTC QLQ CIPN20) on cycle 1 day 1 of chemotherapy, then at 3, 6, 9, 12 weeks into your treatment There will be no additional visits. Your oncologist will not see the results of these questionnaires so if you have symptoms you should also discuss these with your oncologist in your clinic appointment. It is hoped this research will demonstrate that EORTC QLQ CIPN20 is more sensitive than standard practice, and could be used to identify neuropathy earlier that would allow modifications to treatment to be made before more severe symptoms develop.

  • A multi-centre, prospective randomised controlled trial to compare modified kinematically aligned total knee arthroplasty using iTKR™ Software with mechanically aligned total knee arthroplasty.

    This is a prospective, multi-centre, randomised, clinical trial to compare the outcomes following two different surgical implant alignment techniques used in total knee replacement surgery. The trial will enrol 102 participants over a 12-month recruitment period between 3 surgeons. The ideal alignment for a total knee replacement (TKR) provides the best outcomes, a stable knee with least pain, best range of motion and overall patient satisfaction and maintains this in the long term. Currently, mechanical alignment is a standard alignment method used to align TKRs. This is an alignment method that places the femoral component (end of the thigh bone) and the tibial component (top of the shin bone) at right angles to the floor when standing, so that the limb forms a straight line. Research has shown that mechanical alignment and the patient’s natural alignment are rarely the same and this is the likely cause for patient discomfort. This led to the development of modified kinematic alignment which looks at the alignment of the two bones that join to the knee, the femur and the tibia. The femur and tibia are aligned on the patient’s own natural axis, rather than the mechanical axis. This is determined by imaging scans such as an x-ray, software, and the surgeon. Most importantly, it places the focus on the patient’s own, natural knee alignment rather than a straight line between the hip and ankle. Study Hypothesis: Patient reported outcomes for robotic modified kinematic total knee replacement using a surgical plan developed using specialist software called iTKR, will be superior to mechanical alignment outcomes. Participants will complete patient reported outcome questionnaires pre-operatively and at 6 months and 2 years post-operatively. Range of motion of the knee will also be measured.

  • AUgmentation of the DIsc: Evaluating the safety and effectiveness of the Kunovus Disc Device (KDD) in maintaining disc height in subjects undergoing single level microdiscectomy for sciatica due to lumbar disc herniation.

    The overall objective of this study is to evaluate the KDD in maintaining disc height in subjects undergoing single level microdiscectomy as measured by DHI.

  • Cognitive Bias Modification for interpretation and Expectancy in Patients with Chronic Pain

    The purpose of this study is to evaluate how effective home-based Cognitive Bias Modification for interpretation (CBM-I) is at reducing pain outcomes for patients with chronic pain. We are also interested in whether education about pain mechanisms and the processes involved in CBM-I will make the intervention more effective. Participants will be randomised to receive internet-delivered CBM-I or a placebo, and will also be randomised to receive psychoeducation or no psychoeducation. We hypothesise that participants in the CBM-I condition will experience a reduction in pain and related measures relative to the placebo, and that CBM-I will be most effective for those who also received psychoeducation.

  • Comparison of Haemodynamic Assessment and Monitoring in Shock (CHAMS1)- a pilot study

    There is minimal evidence that the use of cardiac output monitor devices leads to an overall change in IV fluid use. We sought to investigate the feasibility of performing a randomised controlled study using calibrated cardiac output monitoring devices in shocked ICU patients and whether the use of these devices led to a difference in total volume of IV fluid administered.

  • The effects of nerve dysfunction upon blood vessels in diabetes.

    This randomised controlled trial aims to establish if there is a correlation between diabetic neuropathy (nerve pathways affected by diabetes) and markers of blood vessel health in response to remote ischaemic conditioning (RIC). Via activation of nerves and beneficial compounds within the blood, RIC is known to protect areas at a distance from damage caused by a more prolonged and serious lack of oxygen-rich arterial blood flow in some patients. Methodology 60 randomly recruited adult participants residing in the Armidale region with type 2 diabetes will have a baseline diabetic history taken, detailed physical examination and measurements collected. Non-invasive cardiovascular physiological measurements will be obtained prior to, during and up to 24 hours after the intervention. The RIC intervention consists of 5 mins upper arm ischaemia (brief cessation of oxygen-rich blood flow), with blood pressure cuff inflation to 200mmHg, followed by 5 mins of complete cuff deflation. This cycle will be repeated 3 times without delay between cycles. In the control group, the intervention will be the same, except cuff pressures inflated to a lower pressure. Venous blood samples will be collected immediately before intervention, then 15 and 60 minutes after RIC. Changes in markers of blood vessel health will be the primary outcome measure. Secondary outcome measures will include changes in blood levels of markers of inflammation and physiological changes of the heart and circulation Results will be correlated with variables. Blood samples will also be tested for blood sugar levels, full blood count, HbA1c (measure of diabetes control), and lipids. Aims of the study The study aims to provide a clearer insight into the mechanisms of RIC, assist in predicting which diabetic patients are most likely to benefit from RIC, and potentially guide the development of new therapeutic strategies for the vascular complications of diabetes.

  • Effects of animal and plant origin diet on sleep health in healthy adults

    Aim: To conduct a crossover longitudinal study to determine whether replacement of protein and fat from animal sources in Omnivore diet(OD) with same proportion of protein and fat from plant origin in Vegan diet ajusted (VDA) while maintain the overall energy intake has an effect on sleep pattern and their day-to-day sleep-wake cycle in healthy adults. Objectives: Primary: 1. To examine the effects of transition (acute or habitual) from OD to VDA and vice versa on sleep and 2. To examine the effects of exposure (post habitual) to VDA and OD and vice versa on sleep. Secondary: To examine the response measures associated with the sleep outcomes of OD and VDA diets. These measures include fasting blood glucose level, blood pressure, mood and alertness, and working memory.

  • The effect of Blephadex™ Eyelid Wipes on the ocular microbiota and comfort in normal healthy participants.

    The purpose of this project was to investigate the effect of daily eyelid cleaning with Blephadex™ Eyelid Wipes on ocular symptoms and signs including Demodex numbers, lipase activity and bacterial culture in normal healthy participants. The lipid layer is a component of the tear film that is essential to providing tear film stability. Previous research has found increased lipases (enzymes that break down lipids) in the tear film of symptomatic contact lens wearers which were associated with higher dry eye history and symptom scores. Coconut oil which contains about 50% lauric acid has been shown to inhibit bacterial lipase production. Demodex is the most prevalent microscopic ectoparasite found on the human skin, predominantly on the face, and its incidence increases with age. High Demodex counts are also associated with increased Staphylococcus aureus and Staphylococcus epidermis bacteria, as the lipase produced by the bacteria is necessary for Demodex to digest the sebum it feeds on. Ocular discomfort has been also been associated with higher Demodex counts. Concomitantly tea tree oil has been shown to be effective for eliminating ocular Demodex and improving subjective ocular symptoms. Blephadex™ Eyelid Wipes, contain tea tree oil and coconut oil, however no studies to date have investigated the efficacy of this commercially available product on number of Demodex, Staphyloccocus Aureus count and lipase production. The aims of this study were to evaluate the effect of using Blephadex™ Eyelid Wipes daily on the (i) units of lipase (ii) number of Demodex (iii) Staphylococcus Aureus count and (iv) Non-Invasive Tear Break-Up Time (NITBUT) and subjective ocular comfort in normal healthy participants. 20 participants were enrolled in this pilot, prospective, single centre, observer masked, within subject design study. Each subject received Blephadex™ Eyelid Wipes and were instructed to use it on one eye only (randomly assigned and unknown to the observer using a sealed envelope system), once daily for a period of 30 days. The contralateral eye received no treatment to be used as the control. At the both the baseline and final visit the same measurements of lipase, Staphylococcus Aureus count, Demodex count, tear film characteristics including NITBUT and subjective ocular comfort were conducted.

  • A pilot study of healthy volunteers to compare the performance of standard nasal oxygen cannula at high flows with the “Optiflow” high flow nasal oxygen (HFNO) system.

    Background: Oxygen therapy has been a cornerstone of medical therapy since 1890. Current nasal oxygen cannula have been in use since 1949. Low flow oxygen via traditional nasal oxygen cannula (up to 15L/min) have been shown to modestly prolong time to desaturation when used while inducing general anaesthesia. High flow (± 60L/min) humidified nasal oxygen (HFNO) has been show to dramatically prolong time to desaturation. Apnoeic oxygenation has become well established clinical practice in recent years. Furthermore a volunteer study showed similar oxygen delivery when HFNO is compared to face mask ventilation. It is not known if similar oxygen delivery can be achieved using traditional cannula at high flows. Also the maximum flows achievable via nasal cannula from commonly available oxygen outlets has not been published. The first part of our study will be to establish this information using a gas flow analyser. Early work by our group has shown typical flows of ±55L/min. Our objective is to test the question of whether standard cannula supplying oxygen at high flows show comparable oxygen delivery to the well-researched proprietary HFNO systems. In addition to this we are interested to ascertain whether either therapy contributes significantly to gastric insufflation. Multiple previous case reports have been published of nasopharyngeal catheters resulting in gastric distension and rupture. No published data is yet available to demonstrate whether nasal cannulae, at high flow can also contribute to this potential complication. Our trial plan is to do a study of 30 healthy volunteers, comparing the oxygen delivery (via transcutaneous oxygen measurement) of HFNO via proprietary (humidified/ warmed) system (Optiflow, Fisher and Paykal, NZ) and comparing it to HFNO via traditional nasal cannula at high flow (±55L/min) and low flow (15L/min). Further parameters recorded and compared include; pharyngeal pressure generated, pharyngeal oxygen concentrations obtained, noise levels and participant comfort. A further key aspect of the study will be to examine whether gastric insufflation, a theoretical consequence of using a HFNO technique, does indeed result. For this, real time gastric ultrasound will be used.

Tags:
  • Finding clinical trials